Skip to main content

Table 1 General preoperative conditions of patients

From: A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal

No

HBp

DM

RD

Treatment

Hb

GHb

Scr

SK

echocardiography

EF

(years)

(years)

(years)

(g/L)

(%)

(μmol/L)

(mmol/L)

(%)

1

10

20

2

HD

120

7.5

596.3

5.6

b,c,d,e,f

36

2

5

24

3

HD

87

6.8

712

5.3

a,b,d,e

52

3

0.3

20

1

Drug

128

8.7

422

4.8

a,b,c

58

4

13

15

2

HD

79

6.2

860

4.8

a,b,d,e

52

5

12

25

3

HD

117

7.6

720

4.2

a,b,e

51

6

7

12

9

PD

107

6.4

650

6.2

a,b,d,e

52

7

10

16

6

Drug

112

5.8

249

5.8

a,b,d,e

54

8

10

10

4

HD

89

5.4

1095

4.7

a,b,c,d

54

9

10

22

3

PD

102

6.5

771

4.1

a,b,d

50

10

1

13

1

HD

107

7.1

1081

5.3

a,b

68

11

1

13

1

HD

95

6.8

1029

5.1

a,b

68

12

1

1

1

HD

80

6.2

893

5.5

a,b,e

58

13

5

10

5

Drug

98

7.5

493

4.6

a,b,d

60

14

3

24

4

HD

128

9.5

691

5.6

a,b,e

60

15

10

0

0.3

HD

109

4.5

459

4.3

a,b,e

62

16

15

0

4

Drug

122

4.8

243

5.1

a,b

65

  1. HBp hypertension, DM diabetic mellitus, RD renal disease, Hb hemoglobin, GHb glycolated hemoglobin, HD hemodialysis, PD peritoneal dialysis, Scr serum creatinine, SK Serum kalium, EF ejection fraction, a Left atrial enlargement, b Left ventricular dysfunction, c pulmonary arterial hypertension, d hydropericardium, e aortic valve calcification, f cardiomegaly